1. Abbastabar H, Hamidifard P, Roustazadeh A, Mousavi SH, Mohseni S, Sepandi M, et al. Relationships between breast cancer and common non-communicable disease risk factors: An ecological study. Asian Pacific Journal of Cancer Prevention. 2013;14(9):5123-5. [DOI:10.7314/APJCP.2013.14.9.5123]

2. Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women's cancers: a grand challenge in global health. The Lancet. 2017;389(10071):847-60. [DOI:10.1016/S0140-6736(16)31392-7] [PMID]

3. Montazeri A, Vahdaninia M, Harirchi I, Harirchi AM, Sajadian A, Khaleghi F, et al. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pacific family medicine. 2008;7(1):1-7. [DOI:10.1186/1447-056X-7-6] [PMID]

4. Pollard JW. Trophic macrophages in development and disease. Nature reviews immunology. 2009;9(4):259-70. [DOI:10.1038/nri2528] []

5. Menbari MN, Rahimi K, Ahmadi A, Mohammadi‐Yeganeh S, Elyasi A, Darvishi N, et al. miR‐483‐3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8> oncogene. Journal of cellular physiology. 2020;235(3):2631-42. [DOI:10.1002/jcp.29167] [PMID]

6. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nature medicine. 2013;19(11):1423-37. [DOI:10.1038/nm.3394] [PMID] []

7. Mahmoodi M, Ferdowsi S, Ebrahimi-Barough S, Kamian S, Ai J. Tissue engineering applications in breast cancer. Journal of Medical Engineering & Technology. 2020;44(4):162-8. [DOI:10.1080/03091902.2020.1757771] [PMID]

8. Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X, et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Molecular cancer. 2019;18(1):1-23. [DOI:10.1186/s12943-019-0976-4] []

9. Pleşca‐Manea L, Pârvu AE, Pârvu M, Taaˇmaş M, Buia R, Puia M. et al. Effects of Melilotus officinalis on acute inflammation. Phytotherapy research. 2002;16(4):316-9. [DOI:10.1002/ptr.875] [PMID]

10. Braga PC, Dal Sasso M, Culici M, Spallino A, Falchi M, Bertelli A, et al. Antioxidant activity of Calendula officinalis extract: inhibitory effects on chemiluminescence of human neutrophil bursts and electron paramagnetic resonance spectroscopy. Pharmacology. 2009;83(6):348-55. [DOI:10.1159/000217583] [PMID]

11. Narimani R, Tarakemeh A, Moghaddam M, Mahmoodi Sourestani M. Phytochemical variation within aerial parts of ferula cupularis populations, an endangered medicinal plant from Iran. Chemistry & Biodiversity. 2021;18(12):e2100551. [DOI:10.1002/cbdv.202100551] [PMID]

12. Bocci G, Di Paolo A, Danesi R. The pharmacological bases of the antiangiogenic activity of paclitaxel. Angiogenesis. 2013;16:481-92. [DOI:10.1007/s10456-013-9334-0] [PMID] []

13. Greenwell M, Rahman P. Medicinal plants: their use in anticancer treatment. International journal of pharmaceutical sciences and research. 2015;6(10):4103.

14. Tian Q-E, Yan M, Cai H-L, Tan Q-Y, Zhang W-Y. Astragalus polysaccharides can regulate cytokine and P-glycoprotein expression in H22 tumor-bearing mice. World Journal of Gastroenterology: WJG. 2012;18(47):7079. [DOI:10.3748/wjg.v18.i47.7079] []

15. Ansari G, Delbari A, Karimi M, Akbari Kamrani AA, Abolfathi Momtaz Y, Sahaf R. et al. The effect of Melilotous Officinalis oil on the physical function of older adults with mild to moderate knee osteoarthritis: A double-blind randomized controlled trial. Iranian Journal of Ageing. 2019;14(2):132-43.

16. Qi H, Wei L, Han Y, Zhang Q, Lau AS-Y, Rong J. et al. Proteomic characterization of the cellular response to chemopreventive triterpenoid astragaloside IV in human hepatocellular carcinoma cell line HepG2. International journal of oncology. 2010;36(3):725-35. [DOI:10.3892/ijo_00000548] [PMID]

17. Huang C, Xu D, Xia Q, Wang P, Rong C, Su Y. et al. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. Journal of Pharmacy and Pharmacology. 2012;64(12):1741-50. [DOI:10.1111/j.2042-7158.2012.01549.x] [PMID]

18. Zhang D, Zhuang Y, Pan J, Wang H, Li H, Yu Y, et al. Investigation of effects and mechanisms of total flavonoids of Astragalus and calycosin on human erythroleukemia cells. Oxidative medicine and cellular longevity. 2012;2012:1-5. https://doi.org/10.1155/2012/781516 [DOI:10.1155/2012/209843] [PMID] []

19. Umer KH, Zeenat F, Ahmad W, Vakil A. Therapeutics, phytochemistry and pharmacology of Iklilul Malik (Astragalus hamosus Linn): A natural Unani Remedy. International Journal of Herbal Medicine .2017; 5(5): 01-05

20. Krasteva I, Momekov G, Zdraveva P, Konstantinov S, Nikolov S. Antiproliferative effects of a flavonoid and saponins from Astragalus hamosus against human tumor cell lines. Pharmacognosy Magazine. 2008;4(16):269-72.

21. Saleem S, Shaharyar MA, Khusroo MJ, Ahmad P, Rahman RU, Ahmad K, et al. Anticancer potential of rhamnocitrin 4′-β-d-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats. Molecular and cellular biochemistry. 2013;384:147-53. [DOI:10.1007/s11010-013-1792-6] [PMID]

22. McCulloch M, See C, Shu X-j, Broffman M, Kramer A, Fan W-y, et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. Journal of Clinical Oncology. 2006;24(3):419-30. [DOI:10.1200/JCO.2005.03.6392]

23. Song M, Yin Y, Zhang J, Zhang B, Bian Z, Quan C, et al. MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. Protein & cell. 2014;5(11):851-61. [DOI:10.1007/s13238-014-0093-5] [PMID] []

24. Chen W, Yuan Y, Li C, Mao H, Liu B, Jiang X. et al. Modulating tumor extracellular matrix by simultaneous inhibition of two cancer cell receptors. Advanced Materials. 2022;34(10):2109376. [DOI:10.1002/adma.202109376] [PMID]

25. MOSESSON MW. Fibrinogen and fibrin structure and functions. Journal of thrombosis and haemostasis. 2005;3(8):1894-904. [DOI:10.1111/j.1538-7836.2005.01365.x] [PMID]

26. Mahmoodi M, Ebrahimi-Barough S, Kamian S, Azami M, Mehri M, Abdi M, et al. Fabrication and characterization of a three-dimensional fibrin gel model to evaluate anti-proliferative effects of Astragalus hamosus plant extract on breast cancer cells. Asian Pacific journal of cancer prevention: APJCP. 2022;23(2):731. [DOI:10.31557/APJCP.2022.23.2.731] [PMID] []

27. Csupor‐Löffler B, Hajdú Z, Zupkó I, Réthy B, Falkay G, Forgo P, et al. Antiproliferative effect of flavonoids and sesquiterpenoids from Achillea millefolium sl on cultured human tumour cell lines. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2009;23(5):672-6. [DOI:10.1002/ptr.2697] [PMID]

28. Zuo K, Zhang X, Zou J, Li D, Lv Z. Establishment of a paclitaxel resistant human breast cancer cell strain (MCF-7/Taxol) and intracellular paclitaxel binding protein analysis. Journal of International Medical Research. 2010;38(4):1428-35. [DOI:10.1177/147323001003800424]

29. Duval K, Grover H, Han L-H, Mou Y, Pegoraro AF, Fredberg J, et al. Modeling physiological events in 2D vs. 3D cell culture. Physiology. 2017;32(4):266-77. [DOI:10.1152/physiol.00036.2016]

30. Seo J, Do Yoo J, Kim M, Shim G, Oh Y-K, Park R-W, et al. Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs. Experimental & Molecular Medicine. 2021;53(10):1592-601. [DOI:10.1038/s12276-021-00688-7] [PMID]

31. Kniebs C, Luengen AE, Guenther D, Cornelissen CG, Schmitz-Rode T, Jockenhoevel S, et al. Establishment of a pre-vascularized 3D lung cancer model in fibrin gel-influence of hypoxia and cancer-specific therapeutics. Frontiers in bioengineering and biotechnology. 2021;9:1-11. [DOI:10.3389/fbioe.2021.761846] [PMID] []

32. Campisi M, Shin Y, Osaki T, Hajal C, Chiono V, Kamm RD. 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes. Biomaterials. 2018;180:117-29. [DOI:10.1016/j.biomaterials.2018.07.014] [PMID] []

33. Pourmorad F, Hosseinimehr S, Shahabimajd N. Antioxidant activity, phenol and flavonoid contents of some selected Iranian medicinal plants. African journal of biotechnology. 2006;5(11): 1142-1145.

34. Shojaii A, Motaghinejad M, Norouzi S, Motevalian M. Evaluation of anti-inflammatory and analgesic activity of the extract and fractions of Astragalus hamosus in animal models. Iranian journal of pharmaceutical research: IJPR. 2015;14(1):263.

35. Yance Jr DR, Sagar SM. Targeting angiogenesis with integrative cancer therapies. Integrative cancer therapies. 2006;5(1):9-29. [DOI:10.1177/1534735405285562] [PMID]

36. Hoseinkhani Z, Norooznezhad F, Rastegari-Pouyani M, Mansouri K. Medicinal plants extracts with antiangiogenic activity: where is the link? Advanced Pharmaceutical Bulletin. 2020;10(3):370. [DOI:10.34172/apb.2020.045] [PMID] []

37. Subbaraj GK, Kumar YS, Kulanthaivel L. Antiangiogenic role of natural flavonoids and their molecular mechanism: an update. The Egyptian Journal of Internal Medicine. 2021;33(1):1-10. [DOI:10.1186/s43162-021-00056-x]

38. Gacche R. Compensatory angiogenesis and tumor refractoriness. Oncogenesis. 2015;4(6):1-8. [DOI:10.1038/oncsis.2015.14] [PMID] []

39. Li X, Qu L, Dong Y, Han L, Liu E, Fang S, et al. A review of recent research progress on the astragalus genus. Molecules. 2014;19(11):18850-80. [DOI:10.3390/molecules191118850] [PMID] []

40. Khater M, Greco F, Osborn HM. Antiangiogenic activity of flavonoids: a systematic review and meta-analysis. Molecules. 2020;25(20):4712. [DOI:10.3390/molecules25204712] [PMID] []